Clinical Trial Update: Prophylactic Efficacy of Relenza Against Influenza A and B

View source ↗

Summary

Completed clinical trial results evaluating whether Relenza (zanamivir) can prevent influenza A and B infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Bronchitis
• Chronic Obstructive Pulmonary Disease
• Influenza Human
• Otitis Media
• Pneumonia
• Sinusitis

Drugs mentioned

• RELENZA (zanamivir)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive, Bronchospasm | Status: COMPLETED | Results posted: 2011-03-04